We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Rising Diagnosis of Viral Meningitis Is Often Delayed

By LabMedica International staff writers
Posted on 10 Jul 2018
Print article
Image: A stained cerebrospinal fluid preparation from a case of acute bacterial (pneumococcal) meningitis. There are numerous neutrophils and bacteria (Photo courtesy of Dr. Edmund S. Cibas, MD).
Image: A stained cerebrospinal fluid preparation from a case of acute bacterial (pneumococcal) meningitis. There are numerous neutrophils and bacteria (Photo courtesy of Dr. Edmund S. Cibas, MD).
As the incidence of bacterial meningitis decreases, the proportion of meningitis cases caused by viruses is increasing and the use of molecular diagnostics has also led to increased recognition of neurological viral infections.

Identification of the cause of meningitis is important to improve clinical care, including reducing unnecessary use of antibiotics and antivirals. Patients with suspected viral meningitis are often treated with antibiotics while a diagnosis of bacterial meningitis is excluded, which results in patients receiving long courses of antibiotics and can extend their hospital stay.

A large team of scientists working with the University of Liverpool (Liverpool, UK) carried out a multicenter prospective observational cohort study of adults with suspected meningitis at 42 hospitals across England. The investigators enrolled 1,126 patients were enrolled between September 30, 2011, and September 30, 2014. There were 638 (57%) patients who had meningitis: 231 (36%) cases were viral, 99 (16%) were bacterial and 267 (42%) had an unknown cause. 41 (6%) cases had other causes.

The team identified cerebrospinal fluid (CSF) samples with a leucocyte count of more than 4 × 106 cells/L from laboratory records and classified them according to pathogen identified (or unknown if none was found). All CSF samples were examined by microscopy and culture. CSF polymerase chain reaction (PCR) was done in the admitting hospitals, regional diagnostic centers, or the University of Liverpool, to test for herpes simplex virus types 1 and 2, varicella zoster virus, and enteroviruses, as well as Streptococcus pneumoniae and Neisseria meningitidis, following national recommendations. They applied a proportional inflation, based on the total number of cases (those recruited and those missed) divided by the actual number recruited into the northwest sites in the prospective study, to the initial estimated northwest incidence data.

The team found that found that diagnosis of meningitis was often delayed due to unnecessary brain scans being performed before lumbar puncture, which is the essential investigation to determine the cause of the illness. The majority of patients (81%) had a brain scan and 70% of those took place before lumbar puncture, otherwise known as a spinal tap. Overall, the specific virus or bacteria causing the illness was not identified for 43% of patients.

The authors concluded that their findings demonstrated that viruses are the predominant cause of adult meningitis in the UK, with enteroviruses and herpesviruses responsible for the majority of cases for which a cause is found. Michael Griffiths, BMedSci, BMBS, DPhil, a senior clinical lecturer and a co-author of the study, said, “Diagnosing a specific cause of meningitis quickly is key to getting patients on the right antibiotics, if needed, or avoiding unnecessary antibiotics in those with viral meningitis. Once viral meningitis has been diagnosed, efforts should focus on treatment of the symptoms and expediting discharge from hospital, which would be less distressing for patients and ease pressures on the NHS. The study was published on June 29, 2018, in the journal The Lancet Infectious Diseases.

Related Links:
University of Liverpool

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Myeloperoxidase Assay
IDK MPO ELISA
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
25-OH-VD Reagent Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.